Review Article
Volume 8 Issue 7 - 2021
Age in Older Adults Alters Intestinal Microbiota
Álvaro Zamudio Tiburcio1* and Silverio Alonso López2
1Gastroenterologist, Intestinal Microbiota Transplantation, Pennsylvania, City Hall Benito Juárez, Mexico City Mexico
2Urologist, Chairman Medical Specialties Naples in Mexico City, Mexico
*Corresponding Author: Álvaro Zamudio Tiburcio, Gastroenterologist, Intestinal Microbiota Transplantation, Pennsylvania, City Hall Benito Juárez, Mexico City Mexico.
Received: May 30, 2021; Published: June 26, 2021




Abstract

Aging is related to changes in the intestinal microbiota that are associated with physiological modifications of the gastrointestinal tract and changes in dietary patterns, together with a deterioration in cognitive and immune function, contributing to the frailty of the elderly.

We carry out a comprehensive analysis, where the physiological bases that occur to generate countless alterations are observed, which can, if not be completely removed, if minimized, so that these human beings, who have almost always left something positive to the Society, they are reimbursed, at least, a little of the much they gave.

Basic concepts about the Intestinal Microbiota are determined, which is the organ of shock in these patients, as well as its frequent dysbiosis, as a preponderant factor of the changes that occur.

Intestinal Microbiota Transplantation is approached as an accepted procedure in not only the management of Clostridiodes difficile, but also of a good number of pathologies.

Keywords: Elderly (E); Intestinal Microbiota (IM); Microbiota (M); Fecal Microbiota Transplantation (FMT); Intestinal Microbiota Transplantation (IMT)

References

  1. Organización Mundial de la Salud. Envejecimiento y Salud (2018).
  2. Pozzi M. “Adulto mayor: un neologismo para disimular la ineludible vejez”. Universitat Pompeau Fabra Barcelona (2016).
  3. Salazar N., et al. “Nutrition and the gut microbiome in the elderly”. Gut Microbes2 (2017): 82-97.
  4. A De Steenhuijsen PWA., et al. “Dysbiosis of upper respiratory tract Microbiota in elderly pneumonia patients”. The ISME Journal1 (2016): 97-108.
  5. Cai T., et al. “Fecal microbiota transplantation in an Elderly patient with mental depression. Letter to the Editor”. International Psychogeriatrics10 (2019): 1-2.
  6. Bedani R., et al. “Potential Benefits of Probiotics, Prebiotics, And Synbiotics on the Intestinal Microbiota of the Elderly. December 2016”. In book: Probiotics, Prebiotics, and Symbiotics (2016): 525-538.
  7. Krumbeck J., et al. “Synbiotics for Improvment Human Health”. Annual Review of Food Science and Technology 9 (2018): 451-479.
  8. Serra J. “Intestinal Microbiota”. Aten Primaria6 (2016): 345-346.
  9. Zhang L., et al. “Characterization Of the gut microbiota in frail elderly patients”. Aging Clinical and Experimental Research (2019).
  10. Claesson MJ., et al. “Composition, variability, and temporal stability of the intestinal Microbiota of the elderly”. Proceedings of the National Academy of Sciences of the United States of America 1 (2011) 4586-4591.
  11. Edited by Jeffrey I Gordon., et al. “What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases”. Microorganisms1 (2019): 14.
  12. Thursby E and Juge N. “Introduction to the human gut microbiota”. Biochemical Journal 11 (2017): 1823-1836.
  13. Odamaki T., et al. “Age-related changes in gut microbiota composition from newborn to Centenarian: a cross-sectional study”. BMC Microbiology 16 (2016): 90.
  14. Hasan N and Yang H. “Factors affecting the composition of the gut microbiota, And its modulation”. Peer Journal 7 (2019): e7502.
  15. O'Toole PW. “Changes in the intestinal microbiota from adulthood through to Old age”. Clinical Microbiology and Infection 4 (2012): 44-46.
  16. Jeffery IB., et al. “Composition and temporal stability of the Gut microbiota in older persons”. The ISME Journal 10 (2016): 170-182.
  17. Choi J., et al. “Influence of Altered Gut Microbiota CompositionOn Aging and Aging-Related Diseases”. Journal of Lifestyle Medicine1 (2018): 1-7.
  18. Vemuri R., et al. “Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective”. BioMed Research International (2018): 13.
  19. Rodríguez JM., et al. “The composition of the gut microbiota throughout life, with an emphasis on Early life”. Microbial Ecology in Health and Disease (2015).
  20. Patel P., et al. “The aging gut and the role of Prebiotics, probiotics, and synbiotics: A review”. Journal of Clinical Gerontology and Geriatrics1 (2013).
  21. Spacova I., et al. “Future of Probiotics and Prebiotics and the Implications for Early Career Researchers”. Frontiers in Microbiology (2020).
  22. Ameneyogbe E., et al. “The Exploitation of probiotics, prebiotics and synbiotics in aquaculture: present Study, limitations and future”. Aquaculture International 28 (2020): 1017-1401.
  23. Nagpal R., et al. “Microbiome and aging: Physiological and mechanistic insights”. The Journal of Nutrition, Health and Aging 4 (2018): 267-285.
  24. Kumar M., et al. “Human gut microbiota and healthy Aging: Recent developments and future prospective”. The Journal of Nutrition, Health and Aging1 (2016): 3-16.
  25. Petersen C and Round JL. “Defining dysbiosis and its influence on host Immunity and disease”. Cell Microbiology7 (2014): 1024-1033.
  26. Wilkins LJ., et al. “Defining Dysbiosis for a Cluster of Chronic Diseases”. Scientific Report 9 (2019): 12918.
  27. De Gruttola AK., et al. “Current understanding of Dysbiosis in disease in human and animal models”. Inflammatory Bowel Diseases5 (2016): 1137-1150.
  28. Carding S., et al. “Dysbiosis of the gut Microbiota in disease”. Microbial Ecology in Health and Disease 26 (2015).
  29. Shimizu Y. “Gut microbiota in common elderly diseases affecting activities of Daily living”. World Journal of Gastroenterology42 (2018): 4750-4758.
  30. Choi J., et al. “Influence of Altered Gut Microbiota Composition On Aging and Aging-Related Diseases”. American Journal of Lifestyle Medicine: SAGE Journals1 (2018): 1-7.
  31. Sangkyu KS and Jazwinski M. “The Gut Microbiota and Healthy Aging: A Mini- Review”. Gerontology 64 (2018): 513-520.
  32. Vemuri R., et al. “Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective”. BioMed Research International (2018): 13.
  33. Edwards JA. “1122.Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)”. Open Forum Infectious Diseases1 (2018): S336.
  34. Asempa TE and Nicolau DP. “Clostridium difficile infection in the elderly: an Update on management”. Clinical Interventions in Aging 12 (2017): 1799-1809.
  35. Jump RLP. “Clostridium difficile infection in older adults”. Aging Health4 (2013): 403-414.
  36. Cheng YW and Fisher M. “The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly”. Current Treatment Options in Gastroenterology3 (2017): 349-362.
  37. Shimizu Y. “Gut microbiota in common elderly diseases affecting activities of Daily living”. World Journal of Gastroenterology42 (2018): 4750-4758.
  38. Hassoun A and Edwards J. “1122.Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)”. Open Forum Infectious Diseases1 (2018): S336.
  39. Borody TJ., et al. “Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions”. Current Gastroenterology Reports8 (2013): 337.
  40. Giles EM., et al. “The future of faecal transplants”. Nature Reviews Microbiology 17 (2019): 719.
  41. Guarner F., et al. “Guías Mundiales de la Organización Mundial de Gastroenterología. Probióticos y prebióticos”. Febrero de (2017).
  42. Liu Y., et al. “Probiotics in Disease Prevention and Treatment”. The Journal of Clinical Pharmacology10 (2018): S164-S179.
  43. Malaguarnera G., et al. “Probiotics in the gastrointestinal diseases of the elderly”. The Journal of Nutrition, Health and Aging4 (2012): 402-410.
  44. Feres M., et al. “The Subgingival periodontal microbiota in the aging mouth”. Periodontology 20001 (2016): 30-53.
  45. Day RLJ., et al. “Probiotics: Current landscape and future horizons”. Future Sci OA 4 (2019): FS0391.
  46. Davani-Davari DD., et al. “Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications”. Foods 3 (2019): 92.
  47. Swanson KS., et al. “Expert consensus document: The International Scientific Association for Probiotics and Prebiotis (ISAPP) consensus statment on the Definition and scope of symbiotics”. Nature Reviews Gastroenterology and Hepatology (2008).
  48. Tzortzis G and Vulevic J. “Galacto-Oligosaccharide Prebiotics”. In Charalampopoulos D, Rastall RA (eds) Prebiotics and Probiotics Science And Technology. Springer. New York, NY.
  49. Hendler R and Zhang Y. “Probiotics in the Treatment of Colorectal Cancer”. Medicines3 (2018): 101.
  50. Kim CY., et al. “Protective Effect of Arabinoxylan against Scopolamine-Induced Learning and Memory Impairment”. Biomolecules and Therapeutics 5 (2014): 467-473.
  51. Smith AP., et al. “An Investigation of the Acute Effects of Oligofructose-Enriched Inulin on Subjective Wellbeing, Mood and Cognitive Performance”. Nutrients11 (2015): 8887-8896.
  52. Neufeld KA., et al. “Neurobehavioural effects of Lactobacillus rhamnosus GG alone And in combination with prebiotics polydextrose and galactooligosaccharide In male rats exposed to early-life stress”. Nutritional Neuroscience 6 (2019): 425-434.
  53. Li W., et al. “Probiotics, prebiotics, And synbiotics for the treatment of dementia”. Medicine5 (2020): e18608.
  54. Sudo N., et al. “Postnatal Microbial colonization programs the hypothalamic–pituitary–adrenal system For stress response in mice”. The Journal of Physiology1 (2004): 263-275.
  55. Schmidt K., et al. “Prebiotic intake reduces the waking cortisol response and alters emotional Bias in healthy volunteers”. Psychopharmacology10 (2015): 1793-1801.
  56. Bartman C., et al. “The influence of the microbiota on the Immune response to transplantation”. Current Opinion in Organ Transplantation - LWW Journals1 (2015): 1-7.
  57. Markowiak P and Śliżewska K. “Effects of Probiotics, Prebiotics, and Synbiotics On Human Health”. Nutrients9 (2017): 1021.
  58. Bengmar SBS. “Pre-, Pro-, Synbiotics and Human Health”. Food Technology And Biotechnology4 (): 464-475.
  59. Cerdó T., et al. “The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity”. Nutrients3 (2019): 635.
  60. Valdés L., et al. “In vitro fermentation of different Fructo-oligosaccharides by Bifidobacterium strains for the selection of Synbiotic combinations”. International Journal of Food Microbiology (2016).
  61. Wollowski I., et al. “Role of probiotics and Prebiotics in colon cancer”. American Journal of Clinical Nutrition 2 451S-455S.
  62. Moroti C., et al. “Effect Of the consumption of a new symbiotic shake on glycemia and cholesterol Levels in elderly people with type 2 diabetes mellitus”. Lipids in Health and Disease 11 (2012): 29.
  63. Flesch Agt., et al. “The Terapeutic Use Of Symbiotics”. Arquivos Brasileiros de Cirurgia Digestiva3 (2014): 206-209.
  64. Kumaria R., et al. “Probiotics, prebiotics, and synbiotics: Current status and future uses for Human health. I book: Trends of Microbial Biotechnology for Sustainable Agriculture and Biomedicine System”. Perspectives for Human Health (2020): 173-190.
  65. Wegh CAM., et al. “Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond”. International Journal of Molecular Sciences19 (2019): 4673.
  66. Johnson CN., et al. “Administration of a Postbiotic Causes Immunomodulatory Responses in Broiler Gut and Reduces Disease Pathogenesis Following Challenge”. Microorganism8 (2019): 268.
  67. Akter S., et al. “Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells”. Journal of Microbiologu and Biotechnology4 (2020).
Citation: Álvaro Zamudio Tiburcio and Silverio Alonso López. “Age in Older Adults Alters Intestinal Microbiota”. EC Gastroenterology and Digestive System 8.7 (2021): 60-68.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 10, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.